Evolent Health Inc Class A (EVH) returns
Evolent Health returns over 10 years
$1,000 invested in Evolent Health ten years ago was worth $203.31 at the close on October 30, 2026, with dividends reinvested: an average return of -14.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +23.2% | — | $1,232 | -0.9% |
| 3 months | +35.2% | — | $1,352 | +2.1% |
| Year to date | +7.5% | — | $1,075 | +11.7% |
| 1 year | -34.8% | — | $651.52 | +12.4% |
| 3 years | -82.2% | -43.7% | $178.27 | +88.5% |
| 5 years | -85.3% | -31.9% | $146.91 | +76.0% |
| 10 years | -79.7% | -14.7% | $203.31 | +316.6% |
Evolent Health return by calendar year
| Year | EVH | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +7.5% | +11.7% | -4.2% |
| 2025 | -64.4% | +17.7% | -82.2% |
| 2024 | -65.9% | +24.9% | -90.8% |
| 2023 | +17.6% | +26.2% | -8.6% |
| 2022 | +1.5% | -18.2% | +19.7% |
| 2021 | +72.6% | +28.7% | +43.9% |
| 2020 | +77.1% | +18.4% | +58.8% |
| 2019 | -54.6% | +31.2% | -85.9% |
| 2018 | +62.2% | -4.6% | +66.8% |
| 2017 | -16.9% | +21.7% | -38.6% |
| 2016 | +22.2% | +12.0% | +10.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: EVH financials
No forecast, no recommendation. This page describes Evolent Health Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.